Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • The Microbiome and Cancer-on-a-Chip with Dr. Hyun Jung Kim

    CRI Tech Impact grantee Dr. Hyun Jung Kim is building a colorectal-cancer-on-a-chip device to better understand how…

    June 22, 2020| Arthur N. Brodsky, PhD
  • CRI Celebrates a Future #Immune2Cancer on June 12

    On Friday, June 12, 2020, the global cancer community joined the Cancer Research Institute’s annual awareness day to amplify the lifesaving potential…

    June 15, 2020| Chary Sathea
  • A Special Message from the Cancer Research Institute

    CRI joins people within science, technology, engineering, and mathematics to pause our work as part of #ShutDownSTEM to…

    June 10, 2020| Jill O'Donnell-Tormey, PhD
  • Recapping ASCO20: The Next Horizons in Immunotherapy

    The 56th Annual ASCO Meeting highlighted advances in checkpoint immunotherapy, cell-based immunotherapies, and bispecific antibodies.

    June 4, 2020| Arthur N. Brodsky, PhD
  • ASCO20 Update: Considerations for Checkpoint Inhibitors Moving Forward

    Results unveiled at ASCO20 increased our understanding of checkpoint immunotherapy in a variety of cancers and circumstances.

    June 1, 2020| Arthur N. Brodsky, PhD
  • ASCO20 Update: Cellular Immunotherapies, Genomics, and COVID-19

    Several promising cellular immunotherapies were discussed at ASCO20, including those for solid cancers; plus updates on the cancer…

    May 31, 2020| Arthur N. Brodsky, PhD
  • Investigating the Innate Immune Receptor NLRP6 with Dr. Chen Shen

    CRI Fellow Dr. Chen Shen is investigating NLRP6, a receptor that can recognize bacteria or viruses and…

    May 28, 2020| Arthur N. Brodsky, PhD
  • Building a Single-Cell Atlas with Dr. Ansuman Satpathy

    Dr. Ansuman Satpathy is building a single-cell atlas to help us better understand why immunotherapy succeeds or…

    May 27, 2020| Arthur N. Brodsky, PhD
  • An Epic Podcast Fundraiser for Cancer Research Returns for a Fourth Year

    While many are adjusting to virtual fundraisers at the moment, the Epic Film Guys now have plenty…

    May 26, 2020| Cierra Howard
Previous Page
1 … 40 41 42 43 44 … 98
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal